Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosis
Katrine Pilely(University of Copenhagen), Peter Garred(University of Copenhagen)
Cited by 32
Related Papers
Pentraxin-3 Serum Levels Are Associated with Disease Severity and Mortality in Patients with Systemic Inflammatory Response Syndrome
|PLoS ONE|2013|79
Cholesterol Crystals Activate the Lectin Complement Pathway via Ficolin-2 and Mannose-Binding Lectin: Implications for the Progression of Atherosclerosis
|The Journal of Immunology|2016|48
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain
|The Journal of Immunology|2021|41
C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques
|Frontiers in Immunology|2017|35
Complementary Roles of the Classical and Lectin Complement Pathways in the Defense against Aspergillus fumigatus
|Frontiers in Immunology|2016|28